Mirae Asset Global Etfs Holdings Ltd. Bristol Myers Squibb CO Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $43.9 Billion
- Q4 2024
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 284,920 shares of BMY stock, worth $17.4 Million. This represents 0.04% of its overall portfolio holdings.
Number of Shares
284,920
Previous 287,962
1.06%
Holding current value
$17.4 Million
Previous $14.9 Million
8.14%
% of portfolio
0.04%
Previous 0.04%
Shares
3 transactions
Others Institutions Holding BMY
# of Institutions
2,765Shares Held
1.56BCall Options Held
28MPut Options Held
28.7M-
Vanguard Group Inc Valley Forge, PA190MShares$11.6 Billion0.19% of portfolio
-
Black Rock Inc. New York, NY159MShares$9.69 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY96MShares$5.86 Billion0.44% of portfolio
-
State Street Corp Boston, MA95.1MShares$5.81 Billion0.22% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA60.3MShares$3.68 Billion0.65% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $130B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...